[1]陈 波,云亚滨,王伟志,等.重症高血压性脑出血患者血清CCL23和STC1水平表达与预后的关系[J].现代检验医学杂志,2025,40(01):143-147+157.[doi:10.3969/j.issn.1671-7414.2025.01.027]
　CHEN Bo,YUN Yabin,WANG Weizhi,et al.Relationship between Serum CCL23，STC1 Level Expression and Prognosis in Patients with Severe Hypertensive Intracerebral Hemorrhage[J].Journal of Modern Laboratory Medicine,2025,40(01):143-147+157.[doi:10.3969/j.issn.1671-7414.2025.01.027]
点击复制

重症高血压性脑出血患者血清CCL23和STC1水平表达与预后的关系()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第40卷
期数:
2025年01期
页码:
143-147+157
栏目:
论著
出版日期:
2025-01-15

文章信息/Info

Title:
Relationship between Serum CCL23，STC1 Level Expression and Prognosis in Patients with Severe Hypertensive Intracerebral Hemorrhage
文章编号:
1671-7414（2025）01-143-06
作者:
陈 波; 云亚滨; 王伟志; 杜俊峰; 范宏燕
（呼和浩特市第一医院神经外科，呼和浩特 010010）
Author(s):
CHEN Bo;  YUN Yabin;  WANG Weizhi;  DU Junfeng;  FAN Hongyan
(Department of Neurosurgery，Hohhot First Hospital, Hohhot 010010，China)
关键词:
趋化因子配体23; 斯钙素蛋白1; 重症高血压性脑出血
分类号:
R743.34；R392.11
DOI:
10.3969/j.issn.1671-7414.2025.01.027
文献标志码:
A
摘要:
目的 探究重症高血压性脑出血（HICH）患者血清趋化因子配体23（CCL23）、斯钙素蛋白1（STC1）水平与临床结局的关系。方法 选取2021 年3 月～ 2023 年3 月于呼和浩特市第一医院神经外科就诊的重症HICH 患者122例为研究对象（HICH 组），同期轻症HICH 患者122 例为轻症组和体检健康者122 例为健康组。HICH 组根据预后情况分为生存组（n=94）和死亡组（n=28）。酶联免疫吸附法（ELISA）检测血清CCL23 和STC1 水平；Spearson 法分析血清CCL23，STC1 水平与GCS 评分的相关性；多因素COX 回归分析HICH 患者预后的影响因素；ROC 曲线分析血清CCL23，STC1 水平对预后的预测价值；Kaplan-Meier 分析血清CCL23，STC1 水平与临床结局的关系。结果 健康组、轻症组和HICH 组血清CCL23（53.32±10.85pg/ml，78.49±11.21pg/ml，112.47±11.53pg/ml），STC1（15.12±2.63ng/ml，19.07±2.58ng/ml，22.15±2.75ng/ml）水平依次升高，差异具有统计学意义（F=856.967，215.043，均P ＜ 0.05）。生存组血清CCL23（108.02±13.51pg/ml），STC1（21.06±3.28ng/ml） 水平低于死亡组（127.41±13.55pg/ml，25.83±3.23ng/ml），格拉斯哥昏迷（GCS）评分（8.95±0.92 分）高于死亡组（7.61±0.77 分），差异具有统计学意义（t=6.663，6.810，7.005，均P ＜ 0.001）。血清CCL23，STC1 水平与GCS 评分呈负相关（r=-0.481，-0.426，P ＜ 0.001）。CCL23[OR（95%CI）：1.240（1.091~1.409）]，STC1[OR（95%CI）：1.754（1.215~2.533）]，GCS 评分[OR（95%CI）：0.087（0.020~0.382）] 是HICH 患者预后不良的影响因素（均P ＜ 0.05）。CCL23，STC1 联合预测HICH 患者预后的AUC（95%CI）为0.939（0.880~0.974），高于单独诊断（Z=1.974，2.040，P=0.048，0.041），联合诊断的敏感度和特异度分别为85.71%，94.68%。CCL23，SCT1 高表达患者随访6 个月生存率（51.06%，56.86%）低于CCL23，STC1 低表达患者（93.33%，91.55%），差异具有统计学意义（Log rank χ2=34.777，23.781，均P ＜ 0.05）。结论 重症HICH 患者血清CCL23，STC1 水平较高，与患者预后密切相关，CCL23，STC1 高表达可能预示患者临床结局较差。
Abstract:
Objective To investigate the relationship between serum C-C motif ligand 23 (CCL23)， Stanniocalcin-1 (STC1) levels and prognosis in patients with severe hypertensive intracerebral hemorrhage (HICH). Methods A total of 122 severe HICH patients who visited the Department of Neurosurgery, Hohhot First Hospital from March 2021 to March 2023 were regarded as the study subjects (HICH group), 122 patients with mild HICH during the same period (mild group) and 122 healthy individuals who underwent physical examinations were considered healthy. HICH patients were separated into survival group（n=94） and death group（n=28）based on prognosis. ELISA was applied to detect serum levels of CCL23 and STC1. Spearson on method was used to analyze correlations and multivariate COX regression was used to investigate the influencing factors of prognosis in HICH patients, and ROC curve was applied to analyze the predictive value of serum CCL23 and STC1 levels for the prognosis. Kaplan-Meier was applied to analyze the relationship between serum CCL23, STC1 levels and clinical outcomes. Results Serum CCL23（53.32±10.85pg/ml，78.49±11.21pg/ml，112.47±11.53pg/ml）and STC1 （15.12±2.63ng/ml，19.07±2.58ng/ ml，22.15±2.75ng/ml）levels in the healthy group, mild disease group and HICH group were increased successively， and the differences was statistically significant (F=856.967，215.043，all P<0.05).The serum levels of CCL23 (108.02±13.51pg/ml) and STC1 (21.06±3.28ng/ml) in the survival group were lower than those in the death group（127.41±13.55 pg/ml，25.83±3.23 ng/ml）， the Glasgow coma (GCS) score (8.95±0.92 ) of the survival group was higher than that of the death group（7.61±0.77）， and the differences were statistically significant (t=6.663，6.810， 7.005，all P<0.001). The serum levels of CCL23 and STC1 were negatively correlated with GCS score (r=-0.481, -0.426, all P<0.001). CCL23 [OR(95%CI)：1.240(1.091 ～ 1.409)], STC [OR(95%CI)：1.754(1.215 ～ 2.533)] and GCS [OR(95%CI)： 0.087(0.020 ～ 0.382)] score were the influencing factors for poor prognosis in HICH patients . The AUC(95%CI) of CCL23 combined STC1 in the prediction of the prognosis of HICH patients was 0.939 (0.880 ～ 0.974) which was higher than that of single diagnosis (Z=1.974, 2.040, P=0.048, 0.041), the sensitivity and specificity of combined diagnosis were 85.71% and 94.68%, respectively. The 6-month follow-up survival rate of patients with high expression of CCL23 and STC1 (51.06% vs 93.33%, 56.86% vs 91.55%) was lower than that of patients with low expression of CCL23 and STC1, and the differences were statistically signrficant (Log rank χ2=34.777, 23.781, all P<0.05). Conclusion The serum levels of CCL23 and STC1 are high in severe HICH patients, which are closely related to their prognosis. High expression of CCL23 and STC1 may indicate poor clinical outcomes in patients.

参考文献/References:

[1] DE OLIVEIRA MANOEL A L. Surger y for spontaneous intracerebral hemorrhage [J]. Critical Care (Landon, England ) , 2020, 24(1): 45.
[2] 冯毅，蔡冰，王峰．血清Tau 蛋白、巨噬细胞炎症蛋白-1α水平变化与重症高血压性脑出血患者临床结局的相关性分析[J]．卒中与神经疾病，2022，29（1）：27-32. FENG Yi, CAI Bing, WANG Feng. Correlation analysi s of ser um t au protein, macrophage inf lammatory protein-1α and clinical outcome of patients with severe hypertensive intracerebral hemorrhage [J]. Stroke and Nervous Diseases, 2022, 29(1): 27-32.
[3] KARAN D.CCL23 i n balancing the a ct of endoplasmic reticulum stress and antitumor immunity in hepatocellular carcinoma [J]. Frontiers in Oncology, 2021, 11: 727583.
[4] FAURA J, BUSTAMANTE A, PENALBA A, et al. CCL23: a chemokine associated with progression from mild cognitive impairment to Alzheimer’s disease[J]. Journal of Alzheimer’s Disease，2020, 73(4): 1585-1595.
[5] SEO Y, SHIN T H, AHN J S, et al. Human tonsilder ived mesenchymal st romal cells maintain proliferating and ROS-regulatory properties via stanniocalcin-1[J]. Cells, 2020, 9(3): 636.
[6] SUN Binda, HE Shu, LIU Bao, et al. Stanniocalcin-1 protected astrocytes from hypoxic damage through the AMPK pathway[J]. Neurochemical Research, 2021, 46(11): 2948-2957.
[7] LI Wei, WU Lixiang, HUANG Baisheng, et al. A pilot study: gut microbiota, metabolism and inflammation in hypertensive intracerebral haemorrhage[J]. Journal of Applied Microbiology, 2022, 133(2): 972-986.
[8] SULLIVAN M N, THAKORE P, KRISHNAN V, et al. Endothelial cell TRPA1 activity exacerbates cerebral hemorrhage during severe hypertension [J].Frontiers in Molecular Biosciences, 2023, 10: 1129435.
[9] 中华医学会神经病学分会，中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2019)[J]．中华神经科杂志，2019，52（12）：994-1005． Chinese Society of Neurology，Chinese Stroke Society，Chinese Medical Association . Chinese guidelines for diagnosis and treatment of acute intracerebral hemorrhage 2019 [J]. Chinese Journal of Neurology, 2019, 52(12): 994-1005.
[10] 李长宝，刘磊，宋保新，等．自发性脑出血患者血清miR-143 和HMGA2 表达水平与预后的预测价值研究[J]. 现代检验医学杂志，2023,38(2):69-74. LI Changbao, LIU Lei, SONG Baoxin, et al. Predictive value of serum miR-143 and HMGA2 expression levels and prognosis in patients with spontaneous intracerebral hemorrhage[J]. Journal of Modern Laboratory Medicine, 2023, 38(2): 69-74.
[11] CHEN Fu, ZHANG Shukui, LI Bingzhen, et al. A review of invasive intracranial pressure monitoring fol lowing surgery for hyper tensive cerebral hemorrhage [J]. Frontiers in Neurology, 2023, 14: 1108722.
[12] ZHANG Huiyuan, LU Xi, HAO Yuehan, et al. Oxidized low-density lipoprotein receptor 1: a novel potential therapeutic target for intracerebral hemorrhage[J]. Neural Regeneration Research, 2022, 17(8): 1795-1801.
[13] WANG Weiwei, WU Jianjun, DAI Xulei, et al. Inhibitory effect of CC chemokine ligand 23 (CCL23)/transcription factor activating enhancer binding protein 4 (TFAP4) on cell proliferation, invasion and angiogenesis in hepatocellular carcinoma[J]. Bioengineered, 2022, 13(1): 1626-1636.
[14] VLACHOGIANNIS P, HILLERED L, ENBLAD P, et al. Elevated levels of several chemokines in the cerebrospinal f luid of patients with subarachnoid hemor rhage are associated with worse clinical outcome[J]. PLoS One, 2023, 18(3): e0282424.
[15] LIN Hongwei, SHEN Jie, ZHU Yu, et al. Serum CCL23 emerges as a biomarker for poor prognosis in patients with intracerebral hemorrhage [J]. Clinica Chimica Acta, 2022, 537: 188-193.
[16] LIN Hongwei, SHEN Jie, ZHU Yu, et al. Elevated serum CCL23 levels at admission predict delayed cerebral ischemia and functional outcome after aneurysmal subarachnoid hemorrhage[J]. Journal Clinical Medicine, 2022, 11(23): 6879.
[17] PALMA P F S, BOCK C, SILVA T S, et al. STC1 and PTHrP modify carbohydrate and lipid metabolism in liver of a teleost fish[J]. Scientific Reports, 2019, 9(1): 723.
[18] CHAO Bin, ZHANG Li l i, PAN Juhua, et al. Stanniocalcin-1 overexpression prevents depressionlike behaviors through inhibition of the ROS/NF-κB signaling pathway [J]. Frontiers in Psychiatry, 2021, 12: 644383.
[19] BI Shaojie, DONG Xinying, WANG Zeying, et al. Salvianolic acid B alleviates neurological injury by upregulating stanniocalcin 1 expression[J]. Annals of Translational Medicine, 2022, 10(13): 739.
[20] WANG Pu, LI Xiaolong, CAO Zhihua.STC1 amel iorates cognit ive impai rment and neuroinflammation of Alzheimer’s disease mice via inhibition of ERK1/2 pathway[J]. Immunobiology, 2021, 226(3): 152092.
[21] JUN Qin, LUO Weijian. Ear ly- st age ser um Stanniocalcin 1 as a predictor of outcome in patients with aneurysmal subarachnoid hemor rhage[J]. Medicine, 2021, 100(51): e28222.

备注/Memo

备注/Memo:
基金项目：呼和浩特市科研计划项目（项目编号：2013- 社发-8）。
作者简介：陈波（1982-），男，硕士研究生，副主任医师，从事脑血管疾病微创治疗及神经危重症疾病诊治，E-mail：n18cax@163.com。
通讯作者：范宏燕（1976-），女，硕士研究生，副主任医师，从事急性脑血管病及神经系统急危重症诊治，E-mail：bffeqqp@163.com。
更新日期/Last Update: 2025-01-15